BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16922415)

  • 1. [Regulation of T-cell anergy by ubiquitin ligases].
    Sakata S
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1437-41. PubMed ID: 16922415
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
    Loeser S; Penninger JM
    Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.
    Jeon MS; Atfield A; Venuprasad K; Krawczyk C; Sarao R; Elly C; Yang C; Arya S; Bachmaier K; Su L; Bouchard D; Jones R; Gronski M; Ohashi P; Wada T; Bloom D; Fathman CG; Liu YC; Penninger JM
    Immunity; 2004 Aug; 21(2):167-77. PubMed ID: 15308098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 ligases in T cell anergy--turning immune responses into tolerance.
    Heissmeyer V; Rao A
    Sci STKE; 2004 Jul; 2004(241):pe29. PubMed ID: 15252218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
    Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
    J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune anergy in T cell signaling].
    Shibasaki F
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():407-13. PubMed ID: 15861689
    [No Abstract]   [Full Text] [Related]  

  • 7. Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.
    Gay DL; Ramón H; Oliver PM
    Immunol Res; 2008; 42(1-3):51-64. PubMed ID: 18827983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.
    Heissmeyer V; Macián F; Im SH; Varma R; Feske S; Venuprasad K; Gu H; Liu YC; Dustin ML; Rao A
    Nat Immunol; 2004 Mar; 5(3):255-65. PubMed ID: 14973438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ubiquitin ligases as T cell anergy factors.
    Mueller DL
    Nat Immunol; 2004 Sep; 5(9):883-90. PubMed ID: 15334084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behind the scenes of anergy: a tale of three E3s.
    Davis M; Ben-Neriah Y
    Nat Immunol; 2004 Mar; 5(3):238-40. PubMed ID: 14985708
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of catalytic activities of HECT ubiquitin ligases.
    Kee Y; Huibregtse JM
    Biochem Biophys Res Commun; 2007 Mar; 354(2):329-33. PubMed ID: 17240353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFAT transcription factors in control of peripheral T cell tolerance.
    Serfling E; Klein-Hessling S; Palmetshofer A; Bopp T; Stassen M; Schmitt E
    Eur J Immunol; 2006 Nov; 36(11):2837-43. PubMed ID: 17039563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells.
    Lin AE; Mak TW
    Curr Opin Immunol; 2007 Dec; 19(6):665-73. PubMed ID: 18036806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3 ubiquitin ligases and their control of T cell autoreactivity.
    Bonnevier JL; Zhang R; Mueller DL
    Arthritis Res Ther; 2005; 7(6):233-42. PubMed ID: 16277698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling.
    Lafont F; Simons K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3180-4. PubMed ID: 11248052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy.
    Powell JD; Lerner CG; Ewoldt GR; Schwartz RH
    J Immunol; 1999 Dec; 163(12):6631-9. PubMed ID: 10586058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance.
    Schartner JM; Fathman CG; Seroogy CM
    Semin Immunol; 2007 Jun; 19(3):188-96. PubMed ID: 17403607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gain-of-function mutation of c-CBL tumor suppressor gene in myeloid neoplasms].
    Ogawa S
    Rinsho Ketsueki; 2011 Mar; 52(3):101-5. PubMed ID: 21471695
    [No Abstract]   [Full Text] [Related]  

  • 20. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells.
    Marengère LE; Mirtsos C; Kozieradzki I; Veillette A; Mak TW; Penninger JM
    J Immunol; 1997 Jul; 159(1):70-6. PubMed ID: 9200440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.